关注
Wenzhu Li
Wenzhu Li
Cardiovascular Research Center, Massachusetts General Hospital
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis
L Ai, S Mu, Y Wang, H Wang, L Cai, W Li, Y Hu
BMC cancer 18, 1-9, 2018
1212018
Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID‐19 patients: a multicenter retrospective study
JY Li, HF Wang, P Yin, D Li, DL Wang, P Peng, WH Wang, L Wang, ...
Journal of Thrombosis and Haemostasis 19 (4), 1038-1048, 2021
692021
Prognostic Value of Neutrophil to Lymphocyte Ratio for In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction
YB Guo T, Cheng B, Ke L, Guan S, Qi B, Li W
Curr Med Sci 38 (2), 354-359, 2018
392018
Time-restricted salutary effects of blood flow restoration on venous thrombosis and vein wall injury in mouse and human subjects
W Li, CW Kessinger, M Orii, H Lee, L Wang, I Weinberg, MR Jaff, GL Reed, ...
Circulation 143 (12), 1224-1238, 2021
342021
TNF‐α Upregulates Fgl2 Expression in Rat Myocardial Ischemia/Reperfusion Injury
P Jia, J Wang, L Wang, X Chen, Y Chen, WZ Li, R Long, J Chen, YW Shu, ...
Microcirculation 20 (6), 524-533, 2013
332013
The significance of microthrombosis and fgl2 in no-reflow phenomenon of rats with acute myocardial ischemia/reperfusion
L Shao, D Wu, P Zhang, W Li, J Wang, G Su, Y Liao, Z Wang, K Liu
Clinical and Applied Thrombosis/Hemostasis 19 (1), 19-28, 2013
322013
Sodium tanshinone IIA sulfonate ameliorates experimental coronary no-reflow phenomenon through down-regulation of FGL2
R Long, Y You, W Li, N Jin, S Huang, T Li, K Liu, Z Wang
Life sciences 142, 8-18, 2015
232015
Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy
G Su, K Liu, Y Wang, J Wang, X Li, W Li, Y Liao, Z Wang
Journal of biomedical research 25 (2), 120-127, 2011
182011
FGL2 prothrombinase contributes to the early stage of coronary microvascular obstruction through a fibrin-dependent pathway
WZ Li, Y Yang, K Liu, R Long, N Jin, SY Huang, Y You, J Dai, C Fan, ...
International journal of cardiology 274, 27-34, 2019
172019
Atorvastatin preconditioning improves the forward blood flow in the no‐reflow rats
L Shao, Y Zhang, A Ma, P Zhang, D Wu, W Li, J Wang, K Liu, Z Wang
Fundamental & clinical pharmacology 28 (1), 42-52, 2014
152014
The FGL2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension
C Fan, J Wang, C Mao, W Li, K Liu, Z Wang
Journal of Applied Physiology 127 (6), 1677-1687, 2019
142019
Role of Kv1. 3 channels in platelet functions and thrombus formation
C Fan, X Yang, WW Wang, J Wang, W Li, M Guo, S Huang, Z Wang, K Liu
Arteriosclerosis, Thrombosis, and Vascular Biology 40 (10), 2360-2375, 2020
122020
Novel antibody against a glutamic acid-rich human fibrinogen-like protein 2-derived peptide near Ser91 Inhibits hfgl2 prothrombinase activity
WZ Li, J Wang, R Long, GH Su, DK Bukhory, J Dai, N Jin, C Fan, K Liu, ...
PloS one 9 (4), e94551, 2014
112014
In Vivo Platelet Detection Using a Glycoprotein IIb/IIIa-Targeted Near-Infrared Fluorescence Imaging Probe
K Ha, X Zheng, CW Kessinger, A Mauskapf, W Li, Y Kawamura, M Orii, ...
ACS sensors 6 (6), 2225-2232, 2021
102021
Mechanism of liver fibrosis and its progress on the latest therapeutic drugs.
HB Chen, W Wu, WZ Li, GY Hu
Journal of Clinical and experimental Medicine (China). 7 (2), 164-165, 2008
10*2008
Intravascular molecular‐structural imaging with a miniaturized integrated near‐infrared fluorescence and ultrasound catheter
S Kellnberger, G Wissmeyer, M Albaghdadi, Z Piao, W Li, A Mauskapf, ...
Journal of biophotonics 14 (10), e202100048, 2021
62021
Pay attention to prevent coronary heart disease-related sudden cardiac death.
ZH Wang, WZ Li
Journal of Clinical Cardiology (China) 32 (7), 651-653, 2016
4*2016
Relationship between coronary microvascular dysfunction and adverse ventricular remodeling after myocardial infarction.
ZH Wang, WZ Li
Journal of Clinical Cardiology (China) 31 (7), 693-695, 2015
3*2015
Review of current therapeutic drugs for anti-liver fibrosis.
HB Chen, W Wu, W Li, A Leng
China Pharmacy. 19 (13), 1021-1023, 2008
3*2008
SVM Communications: Venous Taskforce update and Society announcements
ST Ahsan, O Esponda, W Li, R Amini, M Shaydakov, J Wheeler, E Fukaya
Vascular Medicine 28 (5), 493-495, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20